Science Explorer Back to mapMap
Discussion
Researcher · Cumberland Pharmaceuticals (United States) · United States

Ines Macias‐Perez

Ines Macias‐Perez publishes mostly in Molecular Biology, Pharmacology and Genetics, on topics such as Inflammatory mediators and NSAID effects, Chronic Lymphocytic Leukemia Research and Eicosanoids and Hypertension Pharmacology.

OpenAlex
World rank
#2,842,111
of 7,710,434 ranked researchers
Rank in United States
#822,812
of 1,627,098
Works
25
Citations
746
Citations per work
29.8
h-index
11
i10-index 13Top 71% in Molecular Biology
Ines Macias‐Perez

What does Ines Macias‐Perez research?

Ines Macias‐Perez's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Medicine (21%).

Everything else: 12 works · 49.2% of their workLife Sciences: 7 works · 29.5% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 29.5% of their workMolecular Biology: 4 works · 18.0% of their workGenetics: 2 works · 6.6% of their workCancer Research: 1 works · 4.9% of their workHealth Sciences: 5 works · 21.3% of their workMedicine: 5 works · 21.3% of their workPharmacology: 2 works · 9.8% of their workGenetics: 2 works · 6.6% of their workPathology and Forensic Medicine: 1 works · 4.9% of their workTHEIR WORKInes Macias‐Perez25works
Life Sciences30%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1249.2%
    1. Biochemistry, Genetics and Molecular Biology729.5%
    1. Medicine521.3%
  1. 1Molecular Biology18% of their works
  2. 2Pharmacology10% of their works
  3. 3Genetics7% of their works
  4. 4Genetics7% of their works
  5. 5Cancer Research5% of their works
  6. 6Pathology and Forensic Medicine5% of their works

Research topics

Which keywords describe Ines Macias‐Perez's research?

The keywords of their largest research topics: Inflammation, Rituximab, Cancer, Cyclooxygenase-2 Inhibitors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Arachidonic Acid and Classification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Inflammation82 topics
  2. Rituximab72 topics
  3. Cancer51 topic
  4. Cyclooxygenase-2 Inhibitors51 topic
  5. Chronic Lymphocytic Leukemia41 topic
  6. Genomic Aberrations41 topic
  7. Arachidonic Acid31 topic
  8. Classification31 topic
  9. Epoxyeicosatrienoic Acids31 topic
  10. Lymphoma31 topic
  11. Anthrax21 topic
  12. Bacterial Physiology21 topic
  13. Estrogen21 topic
  14. Gene Regulation21 topic
  15. Matrix Metalloproteinases21 topic
  16. Receptor21 topic
  17. Tissue Inhibitors of Metalloproteinases21 topic
  18. Tularemia21 topic

Where does Ines Macias‐Perez work?

Ines Macias‐Perez's main affiliation in the publication record is Cumberland Pharmaceuticals (United States), United States.

How many publications and citations does Ines Macias‐Perez have?

OpenAlex counts 25 works and 746 citations for Ines Macias‐Perez, an h-index of 11, ranking #2,842,111 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ines Macias‐Perez. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.